Product
BIVV020
Aliases
BIVV020 (SAR445088)
1 clinical trial
1 indication
Indication
Transplant RejectionClinical trial
A Multi-cohort, Randomized, Phase 2, Open-label Study to Assess the Preliminary Efficacy, Safety, and Pharmacokinetics of BIVV020 for Prevention and Treatment of Antibody-mediated Rejection in Adult Kidney Transplant Recipients.Status: Recruiting, Estimated PCD: 2024-11-14